Home  »  Hot Stocks   »  Gossamer Bio Inc. (GOSS) Stock: A Value Analysis...

Gossamer Bio Inc. (GOSS) Stock: A Value Analysis

Moreover, the 36-month beta value for GOSS is 1.18. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 1 as “sell.”

The public float for GOSS is 89.93M and currently, short sellers hold a 17.54% of that float. On May 25, 2023, GOSS’s average trading volume was 3.17M shares.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


GOSS) stock’s latest price update

The stock price of Gossamer Bio Inc. (NASDAQ: GOSS) has plunged by -1.50 when compared to previous closing price of 1.33, but the company has seen a -7.75% decline in its stock price over the last five trading sessions.

GOSS’s Market Performance

Gossamer Bio Inc. (GOSS) has seen a -7.75% fall in stock performance for the week, with a 12.45% gain in the past month and a -24.28% plunge in the past quarter. The volatility ratio for the week is 11.80%, and the volatility levels for the past 30 days are at 10.81% for GOSS. The simple moving average for the last 20 days is -1.65% for GOSS stock, with a simple moving average of -78.14% for the last 200 days.

GOSS Trading at 8.04% from the 50-Day Moving Average

After a stumble in the market that brought GOSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.38% of loss for the given period.

Volatility was left at 10.81%, however, over the last 30 days, the volatility rate increased by 11.80%, as shares surge +2.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.89% lower at present.

During the last 5 trading sessions, GOSS fell by -8.80%, which changed the moving average for the period of 200-days by -90.02% in comparison to the 20-day moving average, which settled at $1.3338. In addition, Gossamer Bio Inc. saw -39.63% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GOSS starting from Giraudo Bryan, who purchase 55,000 shares at the price of $1.02 back on Apr 04. After this action, Giraudo Bryan now owns 125,990 shares of Gossamer Bio Inc., valued at $56,094 using the latest closing price.

Hasnain Faheem, the President & CEO of Gossamer Bio Inc., purchase 440,500 shares at $1.14 during a trade that took place back on Mar 22, which means that Hasnain Faheem is holding 4,495,897 shares at $503,580 based on the most recent closing price.


To wrap up, the performance of Gossamer Bio Inc. (GOSS) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.